US Patent Issued to Massachusetts Eye and Ear Infirmary on Aug. 19 for "Methods of treating sensorineural hearing loss using fibroblast growth factor 2 (FGF2)" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,510, issued on Aug. 19, was assigned to Massachusetts Eye and Ear Infirmary (Boston).

"Methods of treating sensorineural hearing loss using fibroblast growth factor 2 (FGF2)" was invented by Konstantina Stankovic (Boston), Nadia A. Atai (Boston), Brad Welling (Boston) and Richard Seist (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of using Fibroblast growth factor 2 (FGF2) to treat subjects with hearing loss associated with impaired word recognition."

The patent was filed on May 29, 2020, under Application No. 17/614,845.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/...